Risk management: The role of regulatory strategies in the development of new medicines
25-26th April 2002, Surrey, UK
The primary objective of the meeting was to develop a global perspective on risk management from both regulators and companies. It was also the intention to develop recommendations to ensure that the number of medicines available worldwide is maximised by:
- A discussion of the regulatory, risk management strategies used in companies during the development of new active substances and how these are changing.
- Reviewing benefit/risk decision making in agencies.
- Sharing experiences of risk management techniques during product development, identifying areas for improvement and good practice, by a review of recent case studies.